Shandong Simcere-Medgenn Bio-pharmaceutical Co., Ltd clinical trials
Acquired by Simcere Pharmaceutical Group Limited, Sep 30, 2006 · source ↗
The registry lists 3 studies whose lead sponsor is Shandong Simcere-Medgenn Bio-pharmaceutical Co., Ltd. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Sep 3, 2014.
Before and after it joined Simcere Pharmaceutical Group Limited
- First submitted before Shandong Simcere-Medgenn Bio-pharmaceutical Co., Ltd became part of Simcere Pharmaceutical Group Limited
- 0
- First submitted after Shandong Simcere-Medgenn Bio-pharmaceutical Co., Ltd became part of Simcere Pharmaceutical Group Limited
- 3
- Unclear, or no submission date
- 0
By the date each study was first submitted to the registry. The registry lists today's sponsor name and keeps no history, so this says when a study was filed, not who filed it.
Registry sponsor names on this page
- Shandong Simcere-Medgenn Bio-pharmaceutical Co., Ltd3 studies
Something wrong with this grouping? Tell us on the Simcere Pharmaceutical Group Limited page.
Studies
Recruiting first, then most recently updated. Showing 3 of 3. All Simcere Pharmaceutical Group Limited studies →
- A Study of Endostar Combined With Chemotherapy for Treatment of OsteosarcomaStatus unknownNCT01002092Phase 2
Sponsor listed in the registry: Shandong Simcere-Medgenn Bio-pharmaceutical Co., Ltd · First submitted after Shandong Simcere-Medgenn Bio-pharmaceutical Co., Ltd became part of Simcere Pharmaceutical Group Limited
- Etoposide-Carboplatin Alone or With Endostar for Extensive Disease Small Cell Lung Cancer (ED-SCLC)CompletedNCT00912392Phase 2
Sponsor listed in the registry: Shandong Simcere-Medgenn Bio-pharmaceutical Co., Ltd · First submitted after Shandong Simcere-Medgenn Bio-pharmaceutical Co., Ltd became part of Simcere Pharmaceutical Group Limited
- Paclitaxel Plus Carboplatin With or Without Endostar in Patients With Advanced Non-small Cell Lung CancerCompletedNCT00708812Phase 2
Sponsor listed in the registry: Shandong Simcere-Medgenn Bio-pharmaceutical Co., Ltd · First submitted after Shandong Simcere-Medgenn Bio-pharmaceutical Co., Ltd became part of Simcere Pharmaceutical Group Limited